Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    16307962 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Premenstrual Symptoms Treatment Comparing Between Oral Contraceptives Containing Desogestrel and Drospirenone
Condition: Premenstrual Syndrome
Interventions: Drug: EE 20 microgram with desogestrel 150 mg;   Drug: EE 20 microgram with drospirenone 3 mg

Study has passed its completion date and status has not been verified in more than two years.